Therapeutic efficacy of trehalose eye drops for treatment of murine dry eye induced by an intelligently controlled environmental system

Molecular Vision

Volumn 18, Issue , 2012, Pages 317-329

  Li, Jinyang ^a   Roubeix, Christophe ^b   Wang, Yu ^a   Shi, Shuai ^a   Liu, Guoting ^a   Baudouin, Christophe ^b,c,d   Chen, Wei ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b INSERM   (France)

^c CENTRE HOSPITALIER NATIONAL D OPHTALMOLOGIE DES QUINZE VINGTS   (France)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EYE PROTEIN; GELATINASE B; HEAT SHOCK PROTEIN 70; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INVOLUCRIN; MESSENGER RNA; OCCLUDIN; SMALL PROLINE RICH PROTEIN 2; TREHALOSE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRY EYE; FEMALE; GELATINASE B GENE; GENE; GENE EXPRESSION; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE GENE; IMMUNOHISTOLOGY; INTERLEUKIN 17 GENE; INTERLEUKIN 1BETA GENE; INTERLEUKIN 2 GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR ALPHA GENE;

ANIMALS; BASE SEQUENCE; CORNEA; CORNIFIED ENVELOPE PROLINE-RICH PROTEINS; CYTOKINES; DISEASE MODELS, ANIMAL; DNA PRIMERS; DRY EYE SYNDROMES; FEMALE; GENE EXPRESSION PROFILING; HSP70 HEAT-SHOCK PROTEINS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 9; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; OPHTHALMIC SOLUTIONS; PROTEIN PRECURSORS; RNA, MESSENGER; TREHALOSE;

EID: 84863047890     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Work Shop (2007). Ocul Surf 2007; 5:75-92. [PMID: 17508116]
2. Baudouin C. [A new approach for better comprehension of diseases of the ocular surface]. J Fr Ophtalmol 2007; 3:239-46. [PMID: 17417148]
3. Pan Z, Wang Z, Yang H, Zhang F, Reinach PS. TRPV1 activation is required for hypertonicity-stimulated inflammatory cytokine release in human corneal epithelial cells. Invest Ophthalmol Vis Sci 2011; 52:485-93. [PMID: 20739465]
4. Doughty MJ, Glavin S. Efficacy of different dry eye treatments with artificial tears or ocular lubricants: a systematic review. Ophthalmic Physiol Opt 2009; 29:573-83. [PMID: 19686307]
5. Luyckx J, Baudouin C. Treahalose: an intriguing disaccharide with potential for medical application in ophthalmology. Clin Ophthalmol 2011; 5:577-81. [PMID: 21654884]
6. Matsuo T. Trehalose protects corneal epithelial cells from death by drying. Br J Ophthalmol 2001; 85:610-2. [PMID: 11316726]
7. Cejková J, Cejka C, Ardan T, Sirc J, Michálek J, Luyckx J. Reduced UVB-induced corneal damage caused by reactive oxygen and nitrogen species and decreased changes in corneal optics after trehalose treatment. Histol Histopathol 2010; 25:1403-16. [PMID: 20865663]
8. Cejková J, Ardan T, Cejka C, Luyckx J. Favorable effects of trehalose on the development of UVB-mediated antioxidant/ pro-oxidant imbalance in the corneal epithelium, proinflammatory cytokine and matrix metalloproteinase induction, and heat shock protein 70 expression. Graefes Arch Clin Exp Ophthalmol 2011; 249:1185-94. [PMID: 21494875]
9. Chen W, Zhang X, Liu M, Zhang J, Ye Y, Lin Y, Luyckx J, Qu J. Trehalose protects against ocular surface disorders in experimental murine dry eye through suppression of apoptosis. Exp Eye Res 2009; 89:311-8. [PMID: 19345212]
10. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Methods 2001; 25:402-8. [PMID: 11846609]
11. Wolkoff P. Ocular discomfort by environmental and personal risk factors altering the precorneal tear film. Toxicol Lett 2010; 199:203-12. [PMID: 20833234]
12. Paschides CA, Stefaniotou M, Papageorgiou J, Skourtis P, Psilas K. Ocular surface and environmental changes. Acta Ophthalmol Scand 1998; 76:74-7. [PMID: 9541438]
13. Dursun D, Wang M, Monroy D, Li DQ, Lokeshwar BL, Stern ME, Pflugfelder SC. A mouse model of keratoconjunctivitissicca. Invest Ophthalmol Vis Sci 2002; 43:632-8. [PMID: 11867577]
14. Barabino S, Shen L, Chen L, Rashid S, Rolando M, Dana MR. The controlled-environment chamber: a new mouse model of dry eye. Invest Ophthalmol Vis Sci 2005; 46:2766-71. [PMID: 16043849]
15. Huet E, Vallée B, Delbé J, Mourah S, Prulière-Escabasse V, Tremouilleres M, Kadomatsu K, Doan S, Baudouin C, Menashi S, Gabison EE. EMMPRIN modulates epithelial barrier function through a MMP-mediated occludin cleavage: implications in dry eye disease. Am J Pathol 2011; 179:1278-86. [PMID: 21777561]
16. Matter K, Balda MS. Occludin and the functions of tight junctions. Int Rev Cytol 1999; 186:117-46. [PMID: 9770298]
17. Eckert RL, Yaffe MB, Crish JF, Murthy S, Rorke EA, Welter JF. Involucrin: structure and role in envelope assembly. J Invest Dermatol 1993; 100:613-7. [PMID: 8098344]
18. De Paiva CS, Corrales RM, Villarreal AL, Farley W, Li DQ, Stern ME, Pflugfelder SC. Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline. Invest Ophthalmol Vis Sci 2006; 47:2847-56. [PMID: 16799024]
19. Nakamura T, Nishida K, Dota A, Matsuki M, Yamanishi K, Kinoshita S. Elevated expression of transglutaminase 1 and keratinization-related proteins in conjunctiva in severe ocular surface disease. Invest Ophthalmol Vis Sci 2001; 42:549-56. [PMID: 11222510]
20. Corrales RM, de Paiva CS, Li DQ, Farley WJ, Henriksson JT, Bergmanson JP, Pflugfelder SC. Entrapment of conjunctival goblet cells by desiccation-induced cornification. Invest Ophthalmol Vis Sci 2011; 52:3492-9. [PMID: 21421863]
21. Pflugfelder SC, Maskin SL, Anderson B, Chodosh J, Holland EJ, De Paiva CS, Bartels SP, Micuda T, Proskin HM, Vogel R. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednoletabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol 2004; 138:444-57. [PMID: 15364229]
22. Brignole F, Pisella PJ, Goldschild M, De Saint Jean M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers in dry eyes: results of a six-month treatment with topical ciclosporin A. Invest Ophthalmol Vis Sci 2001; 42:90-5. [PMID: 11133852]
23. Baudouin C, Liang H, Bremond-Gignac D, Hamard P, Hreiche R, Creuzot-Garcher C, Warnet JM, Brignole-Baudouin F. CCR 4 and CCR 5 expression in conjunctival specimens as differential markers of T(H)1/ T(H)2 in ocular surface disorders. J Allergy Clin Immunol 2005; 116:614-9. [PMID: 16159632]
24. Chauhan SK, Dana R. Role of Th17 cells in the immunopathogenesis of dry eye disease. Mucosal Immunol 2009; 2:375-6. [PMID: 19532120]
25. Zheng X, de Paiva CS, Li DQ, Farley WJ, Pflugfelder SC. Desiccating stress promotion of Th17 differentiation by ocular surface tissues through a dendritic cell-mediated pathway. Invest Ophthalmol Vis Sci 2010; 51:3083-91. [PMID: 20130281]
26. De Paiva CS, Chotikavanich S, Pangelinan SB, Pitcher JD 3rd, Fang B, Zheng X, Ma P, Farley WJ, Siemasko KF, Niederkorn JY, Stern ME, Li DQ, Pflugfelder SC. IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol 2009; 2:243-53. [PMID: 19242409]
27. McGeachy MJ, Cua DJ. Th17 cell differentiation: the long and winding road. Immunity 2008; 28:445-53. [PMID: 18400187]
28. Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. Curr Eye Res 1999; 19:201-11. [PMID: 10487957]
29. Pauloin T, Dutot M, Joly F, Warnet JM, Rat P. High molecular weight hyaluronan decreases UVB-induced apoptosis and inflammation in human epithelial corneal cells. Mol Vis 2009; 15:577-83. [PMID: 19325714]
30. Brignole F, Pisella PJ, Dupas B, Baeyens V, Baudouin C. Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis. Graefes Arch Clin Exp Ophthalmol 2005; 243:531-8. [PMID: 15965673]
31. Corrales RM, Stern ME, De Paiva CS, Welch J, Li DQ, Pflugfelder SC. Desiccating stress stimulates expression of matrix metalloproteinases by the corneal epithelium. Invest Ophthalmol Vis Sci 2006; 47:3293-302. [PMID: 16877394]
32. Chotikavanich S, de Paiva CS. Li de Q, Chen JJ, Bian F, Farley WJ, Pflugfelder SC. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest Ophthalmol Vis Sci 2009; 50:3203-9. [PMID: 19255163]
33. Pflugfelder SC, Farley W, Luo L, Chen LZ, de Paiva CS, Olmos LC, Li DQ, Fini ME. Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye. Am J Pathol 2005; 166:61-71. [PMID: 15632000]
34. Beardsley RM, De Paiva CS, Power DF, Pflugfelder SC. Desiccating stress decreases apical corneal epithelial cell size-modulation by the metalloproteinase inhibitor doxycycline. Cornea 2008; 27:935-40. [PMID: 18724157]
35. Li DQ, Lokeshwar BL, Solomon A, Monroy D, Ji Z, Pflugfelder SC. Regulation of MMP-9 production by human corneal epithelial cells. Exp Eye Res 2001; 73:449-59. [PMID: 11825017]
36. Ostberg JR, Kaplan KC, Repasky EA. Induction of stress proteins in a panel of mouse tissues by fever-range whole body hyperthermia. Int J Hyperthermia 2002; 18:552-62. [PMID: 12537754]
37. Patel B, Khaliq A, Jarvis-Evans J, Boulton M, Arrol S, Mackness M, McLeod D. Hypoxia induces HSP 70 gene expression in human hepatoma (HEP G2) cells. Biochem Mol Biol Int 1995; 36:907-12. [PMID: 8528154]
38. Kukreja RC, Kontos MC, Loesser KE, Batra SK, Qian YZ, Gbur CJ Jr, Naseem SA, Jesse RL, Hess ML. Oxidant stress increases heat shock protein 70 mRNA in isolated perfused rat heart. Am J Physiol 1994; 267:H2213-9. [PMID: 7810720]
39. Ravindran RK, Tablin F, Crowe JH, Oliver AE. Resistance to dehydration damage in HeLa cells correlates with the presence of endogenous heat shock proteins. Cell Preserv Technol 2005; 3:155-64.
40. Hartl FU, Hayer-Hartl M. Converging concepts of protein folding in vitro and in vivo. Nat Struct Mol Biol 2009; 16:574-81. [PMID: 19491934]
41. Matsuo T. Trehalose versus hyaluronan or cellulose in eyedrops for the treatment of dry eye. Jpn J Ophthalmol 2004; 48:321-7. [PMID: 15295655]
42. Herdeiro RS, Pereira MD, Panek AD, Eleutherio EC. Trehalose protects Saccharomyces cerevisiae from lipid peroxidation during oxidative stress. Biochim Biophys Acta 2006; 1760:340-6. [PMID: 16510250]
43. Benaroudj N, Lee DH, Goldberg AL. Trehalose accumulation during cellular stress protects cells and cellular proteins from damage by oxygen radicals. J Biol Chem 2001; 276:24261-7. [PMID: 11301331]
44. Minutoli L, Altavilla D, Bitto A, Polito F, Bellocco E, Laganà G, Giuliani D, Fiumara T, Magazù S, Ruggeri P, Guarini S, Squadrito F. The disaccharide trehalose inhibits proinflammatory phenotype activation in macrophages and prevents mortality in experimental septic shock. Shock 2007; 27:91-6. [PMID: 17172986]
45. Taya K, Hirose K, Hamada S. Trehalose inhibits inflammatory cytokine production by protecting IkappaB-alpha reduction in mouse peritoneal macrophages. Arch Oral Biol 2009; 54:749-56. [PMID: 19505677]